Pulmonary infections and resistance to antibiotics: recent information.
Identifieur interne : 000302 ( Main/Exploration ); précédent : 000301; suivant : 000303Pulmonary infections and resistance to antibiotics: recent information.
Auteurs : Antoni Torres [Espagne] ; Michael S. Niederman ; Antonio Artigas ; Jean CarletSource :
- Expert review of anti-infective therapy [ 1744-8336 ] ; 2012.
Descripteurs français
- KwdFr :
- Antibactériens (pharmacologie), Antibactériens (usage thérapeutique), Espagne (MeSH), Grippe humaine (complications), Grippe humaine (traitement médicamenteux), Humains (MeSH), Infection croisée (microbiologie), Infection croisée (traitement médicamenteux), Infections de l'appareil respiratoire (microbiologie), Infections de l'appareil respiratoire (traitement médicamenteux), Pneumopathie bactérienne (microbiologie), Pneumopathie bactérienne (traitement médicamenteux), Résistance bactérienne aux médicaments (MeSH), Sous-type H1N1 du virus de la grippe A (MeSH), Staphylococcus aureus résistant à la méticilline (effets des médicaments et des substances chimiques), Unités de soins intensifs (MeSH), Études multicentriques comme sujet (MeSH).
- MESH :
- effets des médicaments et des substances chimiques : Staphylococcus aureus résistant à la méticilline.
- microbiologie : Infection croisée, Infections de l'appareil respiratoire, Pneumopathie bactérienne.
- pharmacologie : Antibactériens, Grippe humaine.
- traitement médicamenteux : Grippe humaine, Infection croisée, Infections de l'appareil respiratoire, Pneumopathie bactérienne.
- usage thérapeutique : Antibactériens.
- Espagne, Humains, Résistance bactérienne aux médicaments, Sous-type H1N1 du virus de la grippe A, Unités de soins intensifs, Études multicentriques comme sujet.
English descriptors
- KwdEn :
- Anti-Bacterial Agents (pharmacology), Anti-Bacterial Agents (therapeutic use), Cross Infection (drug therapy), Cross Infection (microbiology), Drug Resistance, Bacterial (MeSH), Humans (MeSH), Influenza A Virus, H1N1 Subtype (MeSH), Influenza, Human (complications), Influenza, Human (drug therapy), Intensive Care Units (MeSH), Methicillin-Resistant Staphylococcus aureus (drug effects), Multicenter Studies as Topic (MeSH), Pneumonia, Bacterial (drug therapy), Pneumonia, Bacterial (microbiology), Respiratory Tract Infections (drug therapy), Respiratory Tract Infections (microbiology), Spain (MeSH).
- MESH :
- chemical , pharmacology : Anti-Bacterial Agents.
- chemical , therapeutic use : Anti-Bacterial Agents.
- complications : Influenza, Human.
- drug effects : Methicillin-Resistant Staphylococcus aureus.
- drug therapy : Cross Infection, Influenza, Human, Pneumonia, Bacterial, Respiratory Tract Infections.
- microbiology : Cross Infection, Pneumonia, Bacterial, Respiratory Tract Infections.
- Drug Resistance, Bacterial, Humans, Influenza A Virus, H1N1 Subtype, Intensive Care Units, Multicenter Studies as Topic, Spain.
Abstract
This yearly international meeting, 'Infections in the Critically Ill Patient' (3-4 February 2012, Barcelona, Spain) attended by 300 people from many different countries, was the 17th edition. This meeting gathers scientists from different horizons: microbiologists, infectious diseases specialists, intensivists and researchers in the fields of the meeting: sepsis, severe infections and pneumonia. This multidisciplinarity allows a rich cross-fertilization and outstanding discussions. This document summarizes the full day devoted to pulmonary infections and resistance to antibiotics.
DOI: 10.1586/eri.12.84
PubMed: 23199396
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pulmonary infections and resistance to antibiotics: recent information.</title>
<author><name sortKey="Torres, Antoni" sort="Torres, Antoni" uniqKey="Torres A" first="Antoni" last="Torres">Antoni Torres</name>
<affiliation wicri:level="3"><nlm:affiliation>Pneumology Department, Clinic Institute of Thorax, Hospital Clinic of Barcelona, Insitut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Pneumology Department, Clinic Institute of Thorax, Hospital Clinic of Barcelona, Insitut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Niederman, Michael S" sort="Niederman, Michael S" uniqKey="Niederman M" first="Michael S" last="Niederman">Michael S. Niederman</name>
</author>
<author><name sortKey="Artigas, Antonio" sort="Artigas, Antonio" uniqKey="Artigas A" first="Antonio" last="Artigas">Antonio Artigas</name>
</author>
<author><name sortKey="Carlet, Jean" sort="Carlet, Jean" uniqKey="Carlet J" first="Jean" last="Carlet">Jean Carlet</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:23199396</idno>
<idno type="pmid">23199396</idno>
<idno type="doi">10.1586/eri.12.84</idno>
<idno type="wicri:Area/Main/Corpus">00270</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00270</idno>
<idno type="wicri:Area/Main/Curation">000270</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000270</idno>
<idno type="wicri:Area/Main/Exploration">000270</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Pulmonary infections and resistance to antibiotics: recent information.</title>
<author><name sortKey="Torres, Antoni" sort="Torres, Antoni" uniqKey="Torres A" first="Antoni" last="Torres">Antoni Torres</name>
<affiliation wicri:level="3"><nlm:affiliation>Pneumology Department, Clinic Institute of Thorax, Hospital Clinic of Barcelona, Insitut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Pneumology Department, Clinic Institute of Thorax, Hospital Clinic of Barcelona, Insitut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Niederman, Michael S" sort="Niederman, Michael S" uniqKey="Niederman M" first="Michael S" last="Niederman">Michael S. Niederman</name>
</author>
<author><name sortKey="Artigas, Antonio" sort="Artigas, Antonio" uniqKey="Artigas A" first="Antonio" last="Artigas">Antonio Artigas</name>
</author>
<author><name sortKey="Carlet, Jean" sort="Carlet, Jean" uniqKey="Carlet J" first="Jean" last="Carlet">Jean Carlet</name>
</author>
</analytic>
<series><title level="j">Expert review of anti-infective therapy</title>
<idno type="eISSN">1744-8336</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (pharmacology)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Cross Infection (drug therapy)</term>
<term>Cross Infection (microbiology)</term>
<term>Drug Resistance, Bacterial (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (MeSH)</term>
<term>Influenza, Human (complications)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Intensive Care Units (MeSH)</term>
<term>Methicillin-Resistant Staphylococcus aureus (drug effects)</term>
<term>Multicenter Studies as Topic (MeSH)</term>
<term>Pneumonia, Bacterial (drug therapy)</term>
<term>Pneumonia, Bacterial (microbiology)</term>
<term>Respiratory Tract Infections (drug therapy)</term>
<term>Respiratory Tract Infections (microbiology)</term>
<term>Spain (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antibactériens (pharmacologie)</term>
<term>Antibactériens (usage thérapeutique)</term>
<term>Espagne (MeSH)</term>
<term>Grippe humaine (complications)</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Humains (MeSH)</term>
<term>Infection croisée (microbiologie)</term>
<term>Infection croisée (traitement médicamenteux)</term>
<term>Infections de l'appareil respiratoire (microbiologie)</term>
<term>Infections de l'appareil respiratoire (traitement médicamenteux)</term>
<term>Pneumopathie bactérienne (microbiologie)</term>
<term>Pneumopathie bactérienne (traitement médicamenteux)</term>
<term>Résistance bactérienne aux médicaments (MeSH)</term>
<term>Sous-type H1N1 du virus de la grippe A (MeSH)</term>
<term>Staphylococcus aureus résistant à la méticilline (effets des médicaments et des substances chimiques)</term>
<term>Unités de soins intensifs (MeSH)</term>
<term>Études multicentriques comme sujet (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Bacterial Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Methicillin-Resistant Staphylococcus aureus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Cross Infection</term>
<term>Influenza, Human</term>
<term>Pneumonia, Bacterial</term>
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Staphylococcus aureus résistant à la méticilline</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Infection croisée</term>
<term>Infections de l'appareil respiratoire</term>
<term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Cross Infection</term>
<term>Pneumonia, Bacterial</term>
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antibactériens</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term>
<term>Infection croisée</term>
<term>Infections de l'appareil respiratoire</term>
<term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Resistance, Bacterial</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Intensive Care Units</term>
<term>Multicenter Studies as Topic</term>
<term>Spain</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Espagne</term>
<term>Humains</term>
<term>Résistance bactérienne aux médicaments</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Unités de soins intensifs</term>
<term>Études multicentriques comme sujet</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This yearly international meeting, 'Infections in the Critically Ill Patient' (3-4 February 2012, Barcelona, Spain) attended by 300 people from many different countries, was the 17th edition. This meeting gathers scientists from different horizons: microbiologists, infectious diseases specialists, intensivists and researchers in the fields of the meeting: sepsis, severe infections and pneumonia. This multidisciplinarity allows a rich cross-fertilization and outstanding discussions. This document summarizes the full day devoted to pulmonary infections and resistance to antibiotics.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23199396</PMID>
<DateCompleted><Year>2013</Year>
<Month>05</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1744-8336</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>10</Volume>
<Issue>10</Issue>
<PubDate><Year>2012</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Expert review of anti-infective therapy</Title>
<ISOAbbreviation>Expert Rev Anti Infect Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>Pulmonary infections and resistance to antibiotics: recent information.</ArticleTitle>
<Pagination><MedlinePgn>1105-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1586/eri.12.84</ELocationID>
<Abstract><AbstractText>This yearly international meeting, 'Infections in the Critically Ill Patient' (3-4 February 2012, Barcelona, Spain) attended by 300 people from many different countries, was the 17th edition. This meeting gathers scientists from different horizons: microbiologists, infectious diseases specialists, intensivists and researchers in the fields of the meeting: sepsis, severe infections and pneumonia. This multidisciplinarity allows a rich cross-fertilization and outstanding discussions. This document summarizes the full day devoted to pulmonary infections and resistance to antibiotics.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Torres</LastName>
<ForeName>Antoni</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Pneumology Department, Clinic Institute of Thorax, Hospital Clinic of Barcelona, Insitut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Niederman</LastName>
<ForeName>Michael S</ForeName>
<Initials>MS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Artigas</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Carlet</LastName>
<ForeName>Jean</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016423">Congress</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Expert Rev Anti Infect Ther</MedlineTA>
<NlmUniqueID>101181284</NlmUniqueID>
<ISSNLinking>1478-7210</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D024881" MajorTopicYN="Y">Drug Resistance, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055624" MajorTopicYN="N">Methicillin-Resistant Staphylococcus aureus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018410" MajorTopicYN="N">Pneumonia, Bacterial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2013</Year>
<Month>5</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">23199396</ArticleId>
<ArticleId IdType="doi">10.1586/eri.12.84</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Catalogne</li>
</region>
<settlement><li>Barcelone</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Artigas, Antonio" sort="Artigas, Antonio" uniqKey="Artigas A" first="Antonio" last="Artigas">Antonio Artigas</name>
<name sortKey="Carlet, Jean" sort="Carlet, Jean" uniqKey="Carlet J" first="Jean" last="Carlet">Jean Carlet</name>
<name sortKey="Niederman, Michael S" sort="Niederman, Michael S" uniqKey="Niederman M" first="Michael S" last="Niederman">Michael S. Niederman</name>
</noCountry>
<country name="Espagne"><region name="Catalogne"><name sortKey="Torres, Antoni" sort="Torres, Antoni" uniqKey="Torres A" first="Antoni" last="Torres">Antoni Torres</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000302 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000302 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= GrippeEspagneV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:23199396 |texte= Pulmonary infections and resistance to antibiotics: recent information. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23199396" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a GrippeEspagneV1
This area was generated with Dilib version V0.6.37. |